Therapeutic effect of Avonex, Rebif and Betaferon on quality of life in multiple sclerosis

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1819|69|10|649-657

ISSN： 1323-1316

Source： PSYCHIATRY AND CLINICAL NEUROSCIENCES, Vol.69, Iss.10, 2015-10, pp. : 649-657

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Costs and quality of life of multiple sclerosis in Germany

By Kobelt Gisela   Berg Jenny   Lindgren Peter   Elias W.   Flachenecker P.   Freidel M.   König N.   Limmroth V.   Straube E.  

The European Journal of Health Economics, Vol. 7, Iss. 2, 2006-07 ,pp. : 34-44

Springer Publishing Company

Access to resources Recommend Favorite

Costs and quality of life in multiple sclerosis in The Netherlands

By Kobelt Gisela   Berg J.   Lindgren P.  

The European Journal of Health Economics, Vol. 7, Iss. 2, 2006-07 ,pp. : 55-64

Springer Publishing Company

Access to resources Recommend Favorite

Costs and quality of life of multiple sclerosis in Switzerland

By Kobelt Gisela   Berg Jenny   Lindgren Peter   Gerfin Andrea   Lutz J.  

The European Journal of Health Economics, Vol. 7, Iss. 2, 2006-07 ,pp. : 86-95

Springer Publishing Company

Access to resources Recommend Favorite

Costs and quality of life of multiple sclerosis in the United Kingdom

By Kobelt Gisela   Berg Jenny   Lindgren P.   Kerrigan J.   Russell N.   Nixon R.  

The European Journal of Health Economics, Vol. 7, Iss. 2, 2006-07 ,pp. : 96-104

Springer Publishing Company

Access to resources Recommend Favorite

Costs and quality of life of multiple sclerosis in Sweden

By Berg Jenny   Lindgren P.   Fredrikson Sten   Kobelt Gisela  

The European Journal of Health Economics, Vol. 7, Iss. 2, 2006-07 ,pp. : 75-85

Springer Publishing Company

Access to resources Recommend Favorite